PCDH9 antisense RNA 1 (PCDH9-AS1)

PCDH9 antisense RNA 1 (PCDH9-AS1) is a long non-coding antisense RNA transcribed from the PCDH9 locus. As an antisense RNA, it is non-protein-coding and is believed to regulate the expression of the sense PCDH9 gene, potentially through chromatin modification and direct promoter/enhancer interactions or DNA demethylation[1][4][6]. Like other antisense lncRNAs, PCDH9-AS1 may influence gene expression at either local (cis) or distal (trans) genomic sites, and is most frequently involved in fine-tuning the expression of its associated sense gene. Direct mechanistic, therapeutic, or biomarker roles for PCDH9-AS1 have not been established in the scientific or clinical literature to date[4][6]. PCDH9-AS1 is distinct from the PCDH9 protein, which is implicated in cancer biology and neurological development, but PCDH9-AS1's main biological role is presumed to be the *epigenetic regulation* or transcriptional control of PCDH9 or nearby loci[1][6]. **Key distinctions:** - PCDH9-AS1 is *not a therapeutic target* (such as a receptor, transporter, enzyme, or signaling protein) and does not have known interacting drugs or direct disease roles described in current databases or literature[4][6]. - The clinical relevance of PCDH9-AS1 is still undefined, and it should not be conflated with PCDH9, the protein-coding gene. If additional structured information becomes available in the future (including disease association, interacting small molecules, or biomarker utility), these fields should be updated accordingly.

Other names

PCDH9-AS1PCDH9 antisense RNA 1 (non-protein coding)